UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 5, 2005
INAMED CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | | 1-9741 | | 59-0920629 |
(State or other jurisdiction
of incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
| | | | |
5540 Ekwill Street
Santa Barbara, California | | 93111-2936 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (805) 683-6761
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
ý Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On May 6, 2005, Medicis Pharmaceutical Corporation (“Medicis”) and Inamed Corporation (“Inamed”) issued a joint press release announcing that they have each received a request for additional information from the Federal Trade Commission pursuant to the notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Medicis’ and Inamed’s pending merger.
For additional information concerning the foregoing, a copy of the joint press release dated May 6, 2005 is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits. The following exhibit is being filed herewith:
99.1 | | Joint Press Release dated May 6, 2005 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| INAMED CORPORATION |
| |
Date: May 6, 2005 | /s/ Joseph A. Newcomb | |
| By: | |
| Joseph A. Newcomb |
| Executive Vice President, Secretary and General
Counsel |
| | | |
3
